Results: *A single dose of 2.5 milligrams per kilogram of Ivectosol™ was effective at interfering with viral replication, and driving viral clearance of the B.1.1.7 COVID-19 variant.
Show this thread
Our patented solubilized Ivermectin, Ivectosol™, shows great potential as an effective treatment for COVID-19! We applied our solubilizing technology to Ivermectin to create a highly soluble formula that requires a fraction of the drug & is much more easily absorbed & processed.pic.twitter.com/Lgd4oXCoWT
-
-
-
* Tests done in vitro showed the same antiviral effect at 5uM Ivectosol™ concentration after 24 hours, and again after 48 hours, against all 3 COVID-19 variants tested: the original B.1.1.7 variant, the South African B.1.351 variant, and the Brazilian P.1 variant.
Show this thread -
While
#vaccines are key in eradicating this pandemic, effective prophylactic & viral treatments are also critical, especially for countries where access to vaccines is limited.Show this thread -
This is just one step in solving the COVID-19 problem & could have important implications for future pandemics as well - stay tuned for updates!
Show this thread
End of conversation
New conversation -
-
-
The world must pay attention to this amazing news
-
It can’t get approved, it will open the floodgates for all IVM to be approved.
End of conversation
New conversation -
-
-
What will be the cost implications?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Time to make some deals and license it out
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Fantastic news..
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Whoop!
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.